

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.49715554 |
| 2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.48003576 |
| 3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.48003576 |
| 4 | modulation by symbiont of host immune response (GO:0052553) | 6.48003576 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 6.48003576 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 6.48003576 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.48003576 |
| 8 | detection of molecule of bacterial origin (GO:0032490) | 5.91236434 |
| 9 | negative regulation of cell killing (GO:0031342) | 5.74229137 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.74229137 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.48607947 |
| 12 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.44648021 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 5.35579566 |
| 14 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 5.28975935 |
| 15 | cellular extravasation (GO:0045123) | 5.19843415 |
| 16 | microglial cell activation (GO:0001774) | 5.19743785 |
| 17 | detection of other organism (GO:0098543) | 5.08183559 |
| 18 | detection of external biotic stimulus (GO:0098581) | 4.92428381 |
| 19 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.88783665 |
| 20 | neutrophil activation involved in immune response (GO:0002283) | 4.87078979 |
| 21 | regulation of gamma-delta T cell activation (GO:0046643) | 4.72721054 |
| 22 | response to peptidoglycan (GO:0032494) | 4.69849295 |
| 23 | negative regulation of interleukin-12 production (GO:0032695) | 4.53142559 |
| 24 | response to host immune response (GO:0052572) | 4.52081792 |
| 25 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.52081792 |
| 26 | leukocyte aggregation (GO:0070486) | 4.48367058 |
| 27 | macrophage activation (GO:0042116) | 4.43448899 |
| 28 | detection of bacterium (GO:0016045) | 4.41920036 |
| 29 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.40883169 |
| 30 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.38038588 |
| 31 | detection of biotic stimulus (GO:0009595) | 4.36096063 |
| 32 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.31648284 |
| 33 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.31075923 |
| 34 | neutrophil mediated immunity (GO:0002446) | 4.15224124 |
| 35 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.13211348 |
| 36 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.12093939 |
| 37 | response to host (GO:0075136) | 4.12093939 |
| 38 | response to host defenses (GO:0052200) | 4.12093939 |
| 39 | neutrophil activation (GO:0042119) | 4.10686951 |
| 40 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.08672317 |
| 41 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.03180331 |
| 42 | respiratory burst (GO:0045730) | 4.02345061 |
| 43 | negative regulation of T cell mediated immunity (GO:0002710) | 3.86921168 |
| 44 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.85162644 |
| 45 | myeloid cell activation involved in immune response (GO:0002275) | 3.82658898 |
| 46 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.76159758 |
| 47 | response to interleukin-15 (GO:0070672) | 3.74352421 |
| 48 | B cell receptor signaling pathway (GO:0050853) | 3.74059884 |
| 49 | myeloid leukocyte mediated immunity (GO:0002444) | 3.71611428 |
| 50 | * negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.70626263 |
| 51 | granulocyte activation (GO:0036230) | 3.68450089 |
| 52 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.64531183 |
| 53 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.59175277 |
| 54 | immunoglobulin mediated immune response (GO:0016064) | 3.58159520 |
| 55 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.43349177 |
| 56 | regulation of mast cell degranulation (GO:0043304) | 3.38700402 |
| 57 | positive regulation of mast cell activation (GO:0033005) | 3.36788216 |
| 58 | negative thymic T cell selection (GO:0045060) | 3.36364701 |
| 59 | activated T cell proliferation (GO:0050798) | 3.33234013 |
| 60 | negative T cell selection (GO:0043383) | 3.32369078 |
| 61 | cellular response to interleukin-15 (GO:0071350) | 3.30821765 |
| 62 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.30339901 |
| 63 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.29570403 |
| 64 | regulation of B cell differentiation (GO:0045577) | 3.29417785 |
| 65 | positive regulation of interferon-alpha production (GO:0032727) | 3.27033383 |
| 66 | positive regulation of B cell differentiation (GO:0045579) | 3.25369415 |
| 67 | positive thymic T cell selection (GO:0045059) | 3.23874522 |
| 68 | regulation of mast cell activation (GO:0033003) | 3.22748847 |
| 69 | * negative regulation of leukocyte mediated immunity (GO:0002704) | 3.19603659 |
| 70 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.17951183 |
| 71 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.17951183 |
| 72 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.17217491 |
| 73 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.16881169 |
| 74 | response to muramyl dipeptide (GO:0032495) | 3.14289359 |
| 75 | dendritic cell migration (GO:0036336) | 3.11983238 |
| 76 | defense response to protozoan (GO:0042832) | 3.09601187 |
| 77 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.09466868 |
| 78 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.07318265 |
| 79 | regulation of interferon-alpha production (GO:0032647) | 3.06034293 |
| 80 | leukocyte degranulation (GO:0043299) | 3.04487543 |
| 81 | positive T cell selection (GO:0043368) | 3.01740766 |
| 82 | germinal center formation (GO:0002467) | 3.00763086 |
| 83 | myeloid leukocyte activation (GO:0002274) | 3.00557383 |
| 84 | T-helper 1 type immune response (GO:0042088) | 2.99893145 |
| 85 | neutrophil chemotaxis (GO:0030593) | 2.99668950 |
| 86 | * regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.97768537 |
| 87 | regulation of leukocyte degranulation (GO:0043300) | 2.92824674 |
| 88 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.92079966 |
| 89 | neutrophil migration (GO:1990266) | 2.92067118 |
| 90 | regulation of macrophage cytokine production (GO:0010935) | 2.89743233 |
| 91 | regulation of tolerance induction (GO:0002643) | 2.88999507 |
| 92 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.87338076 |
| 93 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.85090349 |
| 94 | cellular response to type I interferon (GO:0071357) | 2.85026480 |
| 95 | type I interferon signaling pathway (GO:0060337) | 2.85026480 |
| 96 | negative regulation of interleukin-6 production (GO:0032715) | 2.84582830 |
| 97 | negative regulation of B cell proliferation (GO:0030889) | 2.84491339 |
| 98 | response to type I interferon (GO:0034340) | 2.84411722 |
| 99 | B cell mediated immunity (GO:0019724) | 2.83682364 |
| 100 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.83535691 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.58177489 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.48506626 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.46799747 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.37532546 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.18370643 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.80172255 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.50816956 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.41303716 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.09090908 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.08600942 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.06880740 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.99251696 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.91963476 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.82961477 |
| 15 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.64952385 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.61372630 |
| 17 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.52025969 |
| 18 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.49836364 |
| 19 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.49250228 |
| 20 | MYB_26560356_Chip-Seq_TH2_Human | 2.44423734 |
| 21 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.43404611 |
| 22 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.27004650 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.24335269 |
| 24 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.22007075 |
| 25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.07902116 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.01745228 |
| 27 | MYB_26560356_Chip-Seq_TH1_Human | 2.00429277 |
| 28 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.96255052 |
| 29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94902986 |
| 30 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.91443538 |
| 31 | MAF_26560356_Chip-Seq_TH1_Human | 1.91079259 |
| 32 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.89863831 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.85128514 |
| 34 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.82784338 |
| 35 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.79798600 |
| 36 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.78977629 |
| 37 | GATA1_22025678_ChIP-Seq_K562_Human | 1.77876404 |
| 38 | UTX_26944678_Chip-Seq_JUKART_Human | 1.63600954 |
| 39 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.62698296 |
| 40 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.61210710 |
| 41 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.59157125 |
| 42 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.58734364 |
| 43 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.55726105 |
| 44 | GATA3_26560356_Chip-Seq_TH2_Human | 1.55474658 |
| 45 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.54850143 |
| 46 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.53084577 |
| 47 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52177850 |
| 48 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.51679708 |
| 49 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.44136885 |
| 50 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.40974179 |
| 51 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39626753 |
| 52 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.38924284 |
| 53 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38541500 |
| 54 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.37002334 |
| 55 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36165088 |
| 56 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35880498 |
| 57 | GATA1_19941826_ChIP-Seq_K562_Human | 1.31305339 |
| 58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.25663605 |
| 59 | MYC_22102868_ChIP-Seq_BL_Human | 1.25136213 |
| 60 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.21848401 |
| 61 | MAF_26560356_Chip-Seq_TH2_Human | 1.21167003 |
| 62 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.20574349 |
| 63 | GATA2_19941826_ChIP-Seq_K562_Human | 1.19485186 |
| 64 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19279261 |
| 65 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11675692 |
| 66 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10470516 |
| 67 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09157486 |
| 68 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.08235065 |
| 69 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.07216229 |
| 70 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06687879 |
| 71 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05981828 |
| 72 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.05780882 |
| 73 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.01282299 |
| 74 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.00622369 |
| 75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99987777 |
| 76 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99797093 |
| 77 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98999593 |
| 78 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98345823 |
| 79 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.97320203 |
| 80 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.96665621 |
| 81 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.96496176 |
| 82 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92486479 |
| 83 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91915786 |
| 84 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.89584852 |
| 85 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87625657 |
| 86 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.82652006 |
| 87 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77168302 |
| 88 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.77072855 |
| 89 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.76386369 |
| 90 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.72408732 |
| 91 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.72303888 |
| 92 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.72207001 |
| 93 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71631493 |
| 94 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.70390338 |
| 95 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.70316527 |
| 96 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.65056798 |
| 97 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.64350225 |
| 98 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.63351478 |
| 99 | * GATA3_26560356_Chip-Seq_TH1_Human | 0.63249762 |
| 100 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.63132164 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 5.35221759 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.80744420 |
| 3 | MP0003303_peritoneal_inflammation | 3.62788961 |
| 4 | MP0003436_decreased_susceptibility_to | 3.55607440 |
| 5 | MP0002419_abnormal_innate_immunity | 3.03966065 |
| 6 | MP0000685_abnormal_immune_system | 2.93053193 |
| 7 | MP0008260_abnormal_autophagy | 2.92311772 |
| 8 | MP0001800_abnormal_humoral_immune | 2.90347047 |
| 9 | MP0000569_abnormal_digit_pigmentation | 2.84272733 |
| 10 | MP0005671_abnormal_response_to | 2.79077894 |
| 11 | MP0009785_altered_susceptibility_to | 2.71172749 |
| 12 | MP0005025_abnormal_response_to | 2.69836731 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.62896479 |
| 14 | MP0005387_immune_system_phenotype | 2.51562707 |
| 15 | MP0001790_abnormal_immune_system | 2.51562707 |
| 16 | MP0002723_abnormal_immune_serum | 2.50660316 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.46441108 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.41579377 |
| 19 | MP0001819_abnormal_immune_cell | 2.38630805 |
| 20 | MP0003172_abnormal_lysosome_physiology | 2.32825153 |
| 21 | MP0006082_CNS_inflammation | 2.26574756 |
| 22 | MP0003300_gastrointestinal_ulcer | 2.15490019 |
| 23 | MP0003828_pulmonary_edema | 2.11057558 |
| 24 | MP0005451_abnormal_body_composition | 2.08823588 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 2.04875156 |
| 26 | MP0003763_abnormal_thymus_physiology | 2.02411356 |
| 27 | MP0005464_abnormal_platelet_physiology | 2.01124997 |
| 28 | MP0002405_respiratory_system_inflammati | 1.93792569 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.88310792 |
| 30 | MP0003191_abnormal_cellular_cholesterol | 1.88155417 |
| 31 | MP0002398_abnormal_bone_marrow | 1.87638556 |
| 32 | MP0004883_abnormal_blood_vessel | 1.84609866 |
| 33 | MP0000716_abnormal_immune_system | 1.84255523 |
| 34 | MP0004381_abnormal_hair_follicle | 1.80494649 |
| 35 | MP0002132_abnormal_respiratory_system | 1.72586672 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.71685349 |
| 37 | MP0003656_abnormal_erythrocyte_physiolo | 1.69068975 |
| 38 | MP0000689_abnormal_spleen_morphology | 1.61342449 |
| 39 | MP0002722_abnormal_immune_system | 1.58575706 |
| 40 | MP0009278_abnormal_bone_marrow | 1.56875719 |
| 41 | MP0004947_skin_inflammation | 1.55693529 |
| 42 | MP0002166_altered_tumor_susceptibility | 1.52493557 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.50500505 |
| 44 | MP0005310_abnormal_salivary_gland | 1.48857667 |
| 45 | MP0009764_decreased_sensitivity_to | 1.46508605 |
| 46 | MP0003183_abnormal_peptide_metabolism | 1.46013946 |
| 47 | MP0010155_abnormal_intestine_physiology | 1.44181045 |
| 48 | MP0002429_abnormal_blood_cell | 1.44167245 |
| 49 | MP0003866_abnormal_defecation | 1.43710351 |
| 50 | MP0002396_abnormal_hematopoietic_system | 1.40254869 |
| 51 | MP0005397_hematopoietic_system_phenotyp | 1.39391321 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.39391321 |
| 53 | MP0000015_abnormal_ear_pigmentation | 1.36563781 |
| 54 | MP0005164_abnormal_response_to | 1.36511072 |
| 55 | MP0000703_abnormal_thymus_morphology | 1.35967752 |
| 56 | MP0002277_abnormal_respiratory_mucosa | 1.35885133 |
| 57 | MP0003690_abnormal_glial_cell | 1.31137850 |
| 58 | MP0000858_altered_metastatic_potential | 1.30822089 |
| 59 | MP0008469_abnormal_protein_level | 1.27090431 |
| 60 | MP0003787_abnormal_imprinting | 1.23017706 |
| 61 | MP0001851_eye_inflammation | 1.18644867 |
| 62 | MP0005075_abnormal_melanosome_morpholog | 1.17189381 |
| 63 | MP0003075_altered_response_to | 1.15612875 |
| 64 | MP0009333_abnormal_splenocyte_physiolog | 1.10088673 |
| 65 | MP0002998_abnormal_bone_remodeling | 1.07987175 |
| 66 | MP0005174_abnormal_tail_pigmentation | 1.06984379 |
| 67 | MP0003221_abnormal_cardiomyocyte_apopto | 1.04542000 |
| 68 | MP0000604_amyloidosis | 1.03993262 |
| 69 | MP0002006_tumorigenesis | 0.95706517 |
| 70 | MP0004484_altered_response_of | 0.93055327 |
| 71 | MP0005166_decreased_susceptibility_to | 0.92225396 |
| 72 | MP0004808_abnormal_hematopoietic_stem | 0.91176185 |
| 73 | MP0003448_altered_tumor_morphology | 0.89059105 |
| 74 | MP0005058_abnormal_lysosome_morphology | 0.89013001 |
| 75 | MP0004130_abnormal_muscle_cell | 0.88263666 |
| 76 | MP0002332_abnormal_exercise_endurance | 0.85229519 |
| 77 | MP0008004_abnormal_stomach_pH | 0.84729481 |
| 78 | MP0001853_heart_inflammation | 0.83279764 |
| 79 | MP0009763_increased_sensitivity_to | 0.80822438 |
| 80 | MP0003045_fibrosis | 0.78092152 |
| 81 | MP0000343_altered_response_to | 0.75781037 |
| 82 | MP0001663_abnormal_digestive_system | 0.74447282 |
| 83 | MP0004510_myositis | 0.72516620 |
| 84 | MP0000249_abnormal_blood_vessel | 0.68285322 |
| 85 | MP0009765_abnormal_xenobiotic_induced | 0.67465622 |
| 86 | MP0002009_preneoplasia | 0.66694471 |
| 87 | MP0000371_diluted_coat_color | 0.65057153 |
| 88 | MP0005376_homeostasis/metabolism_phenot | 0.64903813 |
| 89 | MP0002138_abnormal_hepatobiliary_system | 0.64520349 |
| 90 | MP0008874_decreased_physiological_sensi | 0.62979736 |
| 91 | MP0003091_abnormal_cell_migration | 0.61148192 |
| 92 | MP0005390_skeleton_phenotype | 0.61135695 |
| 93 | MP0003329_amyloid_beta_deposits | 0.60770839 |
| 94 | MP0001958_emphysema | 0.60603284 |
| 95 | MP0008057_abnormal_DNA_replication | 0.60216942 |
| 96 | MP0001986_abnormal_taste_sensitivity | 0.58069421 |
| 97 | MP0005388_respiratory_system_phenotype | 0.57034370 |
| 98 | MP0002133_abnormal_respiratory_system | 0.57034370 |
| 99 | MP0008877_abnormal_DNA_methylation | 0.55432927 |
| 100 | MP0003795_abnormal_bone_structure | 0.52376742 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 6.41363944 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.40658129 |
| 3 | Recurrent abscess formation (HP:0002722) | 6.16484775 |
| 4 | Myositis (HP:0100614) | 5.59673142 |
| 5 | Orchitis (HP:0100796) | 5.57187616 |
| 6 | Optic neuritis (HP:0100653) | 5.56585547 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 5.56585547 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.94855329 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.94308090 |
| 10 | Stomatitis (HP:0010280) | 4.56017908 |
| 11 | Gastrointestinal infarctions (HP:0005244) | 4.51175735 |
| 12 | Recurrent fungal infections (HP:0002841) | 4.47585604 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.20749411 |
| 14 | Recurrent skin infections (HP:0001581) | 4.18318889 |
| 15 | Keratoconjunctivitis sicca (HP:0001097) | 4.16461500 |
| 16 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 4.07603079 |
| 17 | T lymphocytopenia (HP:0005403) | 4.02380744 |
| 18 | Mediastinal lymphadenopathy (HP:0100721) | 3.94159605 |
| 19 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.91362900 |
| 20 | Keratoconjunctivitis (HP:0001096) | 3.86792596 |
| 21 | Abnormality of T cell number (HP:0011839) | 3.86719023 |
| 22 | Spontaneous hematomas (HP:0007420) | 3.83982162 |
| 23 | Meningitis (HP:0001287) | 3.83294992 |
| 24 | Recurrent cutaneous fungal infections (HP:0011370) | 3.82926077 |
| 25 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.82926077 |
| 26 | Gingivitis (HP:0000230) | 3.82694948 |
| 27 | Encephalitis (HP:0002383) | 3.66346666 |
| 28 | Obstructive lung disease (HP:0006536) | 3.64017751 |
| 29 | Chronic obstructive pulmonary disease (HP:0006510) | 3.64017751 |
| 30 | Peritonitis (HP:0002586) | 3.55585466 |
| 31 | Vasculitis (HP:0002633) | 3.50719520 |
| 32 | Gingival bleeding (HP:0000225) | 3.49946975 |
| 33 | Arterial thrombosis (HP:0004420) | 3.35356489 |
| 34 | Urticaria (HP:0001025) | 3.26923845 |
| 35 | Hemoptysis (HP:0002105) | 3.21062869 |
| 36 | Leukocytosis (HP:0001974) | 3.18902121 |
| 37 | Prolonged bleeding time (HP:0003010) | 3.17635611 |
| 38 | Chest pain (HP:0100749) | 3.16973930 |
| 39 | Pulmonary infiltrates (HP:0002113) | 2.99793840 |
| 40 | Cellulitis (HP:0100658) | 2.96539573 |
| 41 | Recurrent viral infections (HP:0004429) | 2.95737914 |
| 42 | Abnormality of T cells (HP:0002843) | 2.90844485 |
| 43 | Epistaxis (HP:0000421) | 2.87545892 |
| 44 | Anorexia (HP:0002039) | 2.81321943 |
| 45 | Episodic fever (HP:0001954) | 2.77868717 |
| 46 | Pulmonary embolism (HP:0002204) | 2.71316209 |
| 47 | Hypochromic microcytic anemia (HP:0004840) | 2.58612944 |
| 48 | Increased IgE level (HP:0003212) | 2.57515245 |
| 49 | Abnormality of the peritoneum (HP:0002585) | 2.51983698 |
| 50 | Inflammation of the large intestine (HP:0002037) | 2.51754538 |
| 51 | Gangrene (HP:0100758) | 2.51560893 |
| 52 | Granulocytopenia (HP:0001913) | 2.50286113 |
| 53 | Amyloidosis (HP:0011034) | 2.50242704 |
| 54 | Osteomyelitis (HP:0002754) | 2.49916226 |
| 55 | Subacute progressive viral hepatitis (HP:0006572) | 2.43948594 |
| 56 | Eosinophilia (HP:0001880) | 2.43850671 |
| 57 | Hypochromic anemia (HP:0001931) | 2.37757326 |
| 58 | Gastrointestinal inflammation (HP:0004386) | 2.34030240 |
| 59 | Abnormality of the pleura (HP:0002103) | 2.33193797 |
| 60 | Viral hepatitis (HP:0006562) | 2.31390515 |
| 61 | Pustule (HP:0200039) | 2.30440098 |
| 62 | Slow saccadic eye movements (HP:0000514) | 2.27110523 |
| 63 | Panhypogammaglobulinemia (HP:0003139) | 2.24938535 |
| 64 | Abnormality of the endocardium (HP:0004306) | 2.23267707 |
| 65 | Sepsis (HP:0100806) | 2.19701447 |
| 66 | Increased IgM level (HP:0003496) | 2.15031943 |
| 67 | Recurrent bronchitis (HP:0002837) | 2.15029533 |
| 68 | Microcytic anemia (HP:0001935) | 2.14087498 |
| 69 | Lymphopenia (HP:0001888) | 2.13548809 |
| 70 | Colitis (HP:0002583) | 2.12554234 |
| 71 | Vertigo (HP:0002321) | 2.12477055 |
| 72 | Abnormality of T cell physiology (HP:0011840) | 2.12382928 |
| 73 | Acute hepatic failure (HP:0006554) | 2.11395471 |
| 74 | Keratitis (HP:0000491) | 2.07718536 |
| 75 | Abnormality of eosinophils (HP:0001879) | 2.07676896 |
| 76 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.05026625 |
| 77 | Glomerulopathy (HP:0100820) | 2.02494915 |
| 78 | Periodontitis (HP:0000704) | 2.02092943 |
| 79 | Autoimmune thrombocytopenia (HP:0001973) | 1.95674588 |
| 80 | Abnormal platelet volume (HP:0011876) | 1.93592280 |
| 81 | Difficulty running (HP:0009046) | 1.93360593 |
| 82 | Acne (HP:0001061) | 1.92879539 |
| 83 | Increased cerebral lipofuscin (HP:0011813) | 1.92590214 |
| 84 | Cheilitis (HP:0100825) | 1.92301051 |
| 85 | Postural instability (HP:0002172) | 1.90542408 |
| 86 | Thrombophlebitis (HP:0004418) | 1.88639050 |
| 87 | Recurrent pneumonia (HP:0006532) | 1.87426005 |
| 88 | Skin ulcer (HP:0200042) | 1.87053946 |
| 89 | Autoimmune hemolytic anemia (HP:0001890) | 1.85923785 |
| 90 | Amaurosis fugax (HP:0100576) | 1.83732393 |
| 91 | Petechiae (HP:0000967) | 1.82161950 |
| 92 | Polyneuropathy (HP:0001271) | 1.81431003 |
| 93 | Skin rash (HP:0000988) | 1.77876267 |
| 94 | IgM deficiency (HP:0002850) | 1.77266538 |
| 95 | Stomach cancer (HP:0012126) | 1.77175107 |
| 96 | Hematochezia (HP:0002573) | 1.76474573 |
| 97 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.76301044 |
| 98 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.76301044 |
| 99 | Abnormality of glycolipid metabolism (HP:0010969) | 1.76301044 |
| 100 | Agammaglobulinemia (HP:0004432) | 1.74973970 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.99222217 |
| 2 | BLK | 3.96937282 |
| 3 | MAP2K3 | 3.16140197 |
| 4 | IRAK4 | 2.95141116 |
| 5 | MAP4K1 | 2.79544047 |
| 6 | CSK | 2.76151523 |
| 7 | TYK2 | 2.66138931 |
| 8 | GRK6 | 2.35122097 |
| 9 | FES | 2.34749905 |
| 10 | FGR | 2.05246644 |
| 11 | TXK | 1.96884464 |
| 12 | ZAP70 | 1.96477869 |
| 13 | JAK3 | 1.94177062 |
| 14 | SYK | 1.88362544 |
| 15 | MAP3K14 | 1.87891482 |
| 16 | BTK | 1.85166784 |
| 17 | IKBKE | 1.78419924 |
| 18 | TAOK3 | 1.77292245 |
| 19 | EPHB1 | 1.75286939 |
| 20 | HCK | 1.62631777 |
| 21 | PRPF4B | 1.58192442 |
| 22 | ERN1 | 1.51648180 |
| 23 | JAK2 | 1.50451497 |
| 24 | IRAK1 | 1.49728674 |
| 25 | JAK1 | 1.44996595 |
| 26 | MAP3K3 | 1.44324601 |
| 27 | MAP3K6 | 1.44088307 |
| 28 | YES1 | 1.43591193 |
| 29 | TNK2 | 1.43309733 |
| 30 | LYN | 1.42450013 |
| 31 | TAOK1 | 1.42128047 |
| 32 | MAP3K2 | 1.40614334 |
| 33 | PIK3CG | 1.35774458 |
| 34 | MAP3K1 | 1.31065542 |
| 35 | BMPR2 | 1.30575043 |
| 36 | TEC | 1.29206095 |
| 37 | KSR2 | 1.27679030 |
| 38 | MAP3K13 | 1.26656003 |
| 39 | ITK | 1.19124074 |
| 40 | MATK | 1.17109554 |
| 41 | IRAK2 | 1.14945804 |
| 42 | FGFR3 | 1.13356705 |
| 43 | PTK2B | 1.09083921 |
| 44 | CSF1R | 1.07924239 |
| 45 | MAP3K11 | 1.07553826 |
| 46 | LCK | 1.07254812 |
| 47 | MARK3 | 1.06262335 |
| 48 | WNK1 | 1.06117829 |
| 49 | FRK | 1.00059234 |
| 50 | SGK2 | 0.98854450 |
| 51 | MARK2 | 0.96950541 |
| 52 | TBK1 | 0.90894518 |
| 53 | LRRK2 | 0.89899703 |
| 54 | MAP2K4 | 0.88552115 |
| 55 | SGK3 | 0.88352735 |
| 56 | KIT | 0.87825078 |
| 57 | NLK | 0.85450955 |
| 58 | MAP3K5 | 0.84087055 |
| 59 | EPHA3 | 0.80518454 |
| 60 | PDK1 | 0.80036718 |
| 61 | IKBKB | 0.77931473 |
| 62 | STK10 | 0.73981989 |
| 63 | TGFBR2 | 0.71185283 |
| 64 | RAF1 | 0.70785361 |
| 65 | CAMKK2 | 0.69614069 |
| 66 | STK11 | 0.68157589 |
| 67 | KSR1 | 0.67663822 |
| 68 | PIM1 | 0.67201270 |
| 69 | PTK6 | 0.65824438 |
| 70 | STK4 | 0.65063938 |
| 71 | MAP2K6 | 0.62912151 |
| 72 | PDPK1 | 0.61985682 |
| 73 | MAP3K7 | 0.61864676 |
| 74 | FYN | 0.59582748 |
| 75 | RET | 0.56719786 |
| 76 | FGFR4 | 0.55379225 |
| 77 | ACVR1B | 0.54586362 |
| 78 | PRKCQ | 0.54072462 |
| 79 | HIPK2 | 0.50932044 |
| 80 | SIK3 | 0.50599823 |
| 81 | MAPK7 | 0.48927639 |
| 82 | SGK223 | 0.48452147 |
| 83 | SGK494 | 0.48452147 |
| 84 | MAPK12 | 0.47588787 |
| 85 | CDC42BPA | 0.45932557 |
| 86 | PRKD2 | 0.45886295 |
| 87 | ERBB2 | 0.45873457 |
| 88 | TAOK2 | 0.45430334 |
| 89 | GRK5 | 0.44222112 |
| 90 | CDK19 | 0.42676782 |
| 91 | TRPM7 | 0.40265661 |
| 92 | DAPK2 | 0.40228895 |
| 93 | DYRK3 | 0.39122285 |
| 94 | CAMK4 | 0.38745275 |
| 95 | DYRK1B | 0.35295838 |
| 96 | STK38 | 0.35282040 |
| 97 | MAPKAPK2 | 0.34515088 |
| 98 | GRK7 | 0.34126333 |
| 99 | PRKAA2 | 0.32808794 |
| 100 | CAMKK1 | 0.32198782 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Leishmaniasis_Homo sapiens_hsa05140 | 3.00968422 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.96388211 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.76752214 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.52103349 |
| 5 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.23543492 |
| 6 | * Tuberculosis_Homo sapiens_hsa05152 | 2.19020317 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.17271609 |
| 8 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.16729873 |
| 9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.10340285 |
| 10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.84614867 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.83263079 |
| 12 | Measles_Homo sapiens_hsa05162 | 1.82740259 |
| 13 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.82205393 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.81288338 |
| 15 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.79264900 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.78855266 |
| 17 | Allograft rejection_Homo sapiens_hsa05330 | 1.76518131 |
| 18 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.71477911 |
| 19 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.66310969 |
| 20 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.63799599 |
| 21 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.60177793 |
| 22 | * Legionellosis_Homo sapiens_hsa05134 | 1.57812013 |
| 23 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.57204562 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.52792642 |
| 25 | * Malaria_Homo sapiens_hsa05144 | 1.51487744 |
| 26 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.49602918 |
| 27 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.49500042 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.49369106 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.41559713 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.34073180 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.32059259 |
| 32 | Phagosome_Homo sapiens_hsa04145 | 1.31879645 |
| 33 | Platelet activation_Homo sapiens_hsa04611 | 1.31440714 |
| 34 | Hepatitis B_Homo sapiens_hsa05161 | 1.26573480 |
| 35 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.26490240 |
| 36 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.20789489 |
| 37 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.19814402 |
| 38 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.16068347 |
| 39 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.13014618 |
| 40 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.11957202 |
| 41 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.11634917 |
| 42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.11103409 |
| 43 | Hepatitis C_Homo sapiens_hsa05160 | 1.06535435 |
| 44 | Asthma_Homo sapiens_hsa05310 | 1.06183042 |
| 45 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.05813348 |
| 46 | Pertussis_Homo sapiens_hsa05133 | 1.02606476 |
| 47 | Viral myocarditis_Homo sapiens_hsa05416 | 1.01264110 |
| 48 | Apoptosis_Homo sapiens_hsa04210 | 1.00410936 |
| 49 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.99827398 |
| 50 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.96746468 |
| 51 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.96293482 |
| 52 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.94826143 |
| 53 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.92841998 |
| 54 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.90987883 |
| 55 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.90211223 |
| 56 | Salmonella infection_Homo sapiens_hsa05132 | 0.87222666 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84704790 |
| 58 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.83847673 |
| 59 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82448257 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.82283541 |
| 61 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.82011011 |
| 62 | Endometrial cancer_Homo sapiens_hsa05213 | 0.79279047 |
| 63 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.79196696 |
| 64 | Shigellosis_Homo sapiens_hsa05131 | 0.76312515 |
| 65 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.75273129 |
| 66 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.73935071 |
| 67 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.72342619 |
| 68 | Other glycan degradation_Homo sapiens_hsa00511 | 0.71429792 |
| 69 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.68505217 |
| 70 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.68317755 |
| 71 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.67666198 |
| 72 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.67652564 |
| 73 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67077280 |
| 74 | Lysosome_Homo sapiens_hsa04142 | 0.65248299 |
| 75 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.64420395 |
| 76 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.64340903 |
| 77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62482648 |
| 78 | Amoebiasis_Homo sapiens_hsa05146 | 0.62246350 |
| 79 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61986902 |
| 80 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.61806514 |
| 81 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61604570 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.59247646 |
| 83 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.57830495 |
| 84 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56347934 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54982379 |
| 86 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.54036906 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.53611460 |
| 88 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.51218754 |
| 89 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.50599910 |
| 90 | Prostate cancer_Homo sapiens_hsa05215 | 0.49670346 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49448513 |
| 92 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.48347490 |
| 93 | Glioma_Homo sapiens_hsa05214 | 0.46537838 |
| 94 | Colorectal cancer_Homo sapiens_hsa05210 | 0.44164402 |
| 95 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42970089 |
| 96 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.42506642 |
| 97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41360430 |
| 98 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.39248011 |
| 99 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38354069 |
| 100 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.38139572 |

